GlaxoSmithKline Plc Chief Executive Officer Andrew Witty

GlaxoSmithKline Plc Chief Executive Officer Andrew Witty

Kiyoshi Ota/Bloomberg

GlaxoSmithKline Plc Chief Executive Officer Andrew Witty said in February that Syncria was “very, very promising.”